Bipolar disorder (BMD) is a dubious disease in the field of the nervous system, clinical performance is complex and often involves multi-system fatigue. Early identification and standardized clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological evaluation.
The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many of the neural system diseases that have previously been difficult to treat have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions, with timely adjustment according to changes in the disease schedule.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of BMD. The platform serves a team of internationally authoritative experts in the field of neural systems related to the International Medical Service System of China, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.